BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI) Proposers' Day

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)

Contract Value

Not provided

Codes & Classification
Solicitation Number

ARPA-H-SN-26-147

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AN13

Additional Details
Set Aside

NONE

Place of Performance

Washington, District of Columbia, UNITED STATES

SourceSAM
Documents2
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a Special Notice (ARPA-H-SN-26-147) to inform the scientific and research community about the newly approved BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI) program. This notice specifically announces the upcoming BIOGAMI Proposers’ Day, an event designed to engage potential proposers and provide critical information regarding the program’s objectives and requirements. The BIOGAMI initiative seeks to advance research and development in the physical, engineering, and life sciences, with a particular focus on understanding and modulating protein aggregation. The program aims to foster innovative approaches and interventions that address challenges related to protein aggregation, which is a key factor in numerous health conditions. The intended outcome is to catalyze scientific breakthroughs that could lead to novel therapeutic strategies and improved health outcomes. ARPA-H encourages interested parties to participate in the Proposers’ Day, where detailed program information, requirements, and expectations will be shared. The event will also feature a Lightning Talk Template, provided as part of Amendment 1 to the Special Notice, enabling participants to succinctly present their ideas and capabilities. All questions submitted in response to the Special Notice will be compiled and addressed, with answers posted regularly to the BIOGAMI Frequently Asked Questions (FAQ) page. Potential proposers are advised to monitor this page for the latest updates and clarifications: https://arpa-h.gov/explore-funding/programs/biogami/faqs. The procurement is classified under NAICS Code 541715, which covers Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and Product Service Code AN13. There are no set-aside requirements for this opportunity, making it open to all qualified entities. The place of performance is Washington, District of Columbia (DC), United States. The contracting entity is ARPA-H, a federal office within the National Institutes of Health. The primary point of contact for this notice is the BIOGAMI Team, who can be reached at [email protected] for further inquiries. Contractors evaluating this opportunity should note that the notice is currently active, with a response deadline of February 19, 2026. All relevant documents, including amendments and templates, are available via the official SAM.gov listing (Opportunity ID: 39726334ae2547e2b0609856528ed303). Interested parties are encouraged to review the attached materials for comprehensive details and to ensure alignment with the program’s scientific and technical objectives. In summary, the BIOGAMI program represents a significant opportunity for organizations specializing in advanced research and development within the life sciences. The Proposers’ Day will serve as a critical platform for information exchange, proposal preparation, and engagement with ARPA-H, supporting the agency’s mission to drive transformative health research.